EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.1 | pharmacology | NNMT as potential biomarker and therapeutic target | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.1 | Homo sapiens | P40261 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.1 | oral mucosa | - |
Homo sapiens | - |
2.1.1.1 | oral squamous cell carcinoma cell line | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.1.1.1 | additional information | - |
expression levels of NNMT in oral squamous cell carcinoma (OSCC), quantitative real-time PCR, Western-Blot and immunohistochemical analyses, upregulation in tumor cells, correlation between NNMT upregulation and favorable prognosis of oral squamous cell carcinoma patients | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | NNMT potential as tumor marker | Homo sapiens | S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.1 | NNMT | - |
Homo sapiens |